One Pager as on March 31, 2026
![]() | Flexibility to invest in opportunities across market capitalization |
![]() | Bottom up stock selection process |
![]() | Active allocation across Market capitalization based on macro-economic indicators, policy environment, valuations, market conditions |
![]() | Top down approach to select sectors |
![]() | Management through diversification of holdings and disciplined approach to monitor individual stock position based on market capitalization |
| Sector | MMFCF* | Nifty 500 TRI |
| Financial Services | 26.86% | 30.83% |
| Information Technology | 8.43% | 7.09% |
| Healthcare | 7.77% | 6.87% |
| Consumer Services | 7.74% | 3.46% |
| Oil Gas & Consumable Fuels | 7.12% | 8.01% |
*Mahindra Manulife Flexi Cap Fund
Data as on March 31, 2026
| Security | % to Net Assets |
| ICICI Bank Limited | 7.90% |
| HDFC Bank Limited | 6.38% |
| Reliance Industries Limited | 4.35% |
| Infosys Limited | 3.57% |
| Axis Bank Limited | 3.03% |
| Larsen & Toubro Limited | 2.89% |
| Tata Consultancy Services Limited | 2.35% |
| Bharti Airtel Limited | 2.34% |
| Bajaj Finance Limited | 2.30% |
| Hindustan Unilever Limited | 2.27% |
| Total | 37.38% |
| Fresh Additions | Complete Exits |
| Security | Security |
| Kotak Mahindra Bank Limited | State Bank of India |
| Sun Pharmaceutical Industries Limited | Tata Motors Ltd |
| Bajaj Auto Limited | Siemens Limited |
| Eternal Limited | ICICI Prudential Life Insurance Company Limited |
| Trent Limited | Swiggy Limited |
| Shriram Finance Limited | Devyani International Limited |
| Dr. Lal Path Labs Limited | ICICI Prudential General Insurance Company Limited |
| Aster DM Healthcare Limited | Lenskart Solutions Limited |
| NMDC Limited | SKF India Limited |
| Escorts Kubota Limited | Hindalco Industries Limited |
| CESC Limited | Petronet LNG Limited |
| K.P.R. Mill Limited | Bata India Limited |
| Anthem Biosciences Limited | Gokaldas Exports Limited |
| Bharat Dynamics Limited | - |
| Radico Khaitan Limited | - |
Note: The companies/stock(s) referred above are only for the purpose of disclosure of significant portfolio
changes during the month and should not be construed as recommendation to buy/sell/ hold. The fund manager
may or may not choose to hold these companies/stocks, from time to time. Investors are requested to consult
their financial, tax and other advisors before taking any investment decision(s). Data as on March 31, 2026
| Turnover Ratio (Last 1 year) | 0.69 |
| Standard Deviation | 13.84% |
| Beta | 0.94 |
| Sharpe Ratio# | 0.36 |
| Jenson's Alpha | -0.0753 |
#Risk-free rate assumed to be 6.98% (MIBOR as on 30-03-2026) - Source:www.mmda.org
Note: As per AMFI guidelines for factsheet, the ratios are calculated based on month rolling returns for last
3 years. Data as on March 30, 2026.
^Benchmark ^^Additional Benchmark. Inception/Allotment date: 23-Aug-21.
Past performance may or may not be sustained in future and should not be used as a basis of comparison with other investments. Since inception returns of the scheme is calculated on face value of Rs. 10 invested at inception. The performance details provided above are of Growth Option
under Regular Plan. Different Plans i.e Regular Plan and Direct Plan under the scheme has different expense structure. Mr. Neelesh Dhamnaskar is managing this scheme since February
16, 2026. *Based on standard investment of Rs. 10,000 made at the beginning of the relevant period.
^Benchmark ^^Additional Benchmark. CAGR – Compounded Annual Growth Rate. Inception/Allotment date: 23-August-21.
Past performance may or may not be sustained in future and should not be used as a basis of comparison with other investments. Returns greater than 1 year period are compounded annualized. For SIP returns, monthly investment of equal
amounts invested on the 1st business day of every month has been considered. CAGR Returns (%) are computed after accounting for the cash flow by using the XIRR method (investment
internal rate of return).
^Benchmark CAGR – Compounded Annual Growth Rate.
Past performance may or may not be sustained in future and should not be used as a basis of comparison with other investments. The performance details provided above
are of Growth Option under Regular Plan. Different Plans i.e Regular Plan and Direct Plan under the scheme has different expense structure. Ms. Fatema Pacha manage 8 schemes
each of Mahindra Manulife Mutual Fund. Mr. Neelesh Dhamnaskar manages 6 schemes each of Mahindra Manulife Mutual Fund. The performance data for the schemes which have not
completed one year has not been provided.
Note: As March 31, 2026 was a non-business days, the schemes returns disclosed are as on March 31, 2026, except for Mahindra Manulife Liquid Fund and Mahindra Manulife Overnight Fund which is
as of March 31, 2026.
This product is suitable for investors who are seeking*:
• Long term capital appreciation.
• Investment in diversified portfolio of
equity & equity related instruments
across market capitalization

*Investors should consult their financial advisers if in doubt about whether the product is suitable for them.